Carla M Gauss

Title: The Innovations of Carla M. Gauss

Introduction

Carla M. Gauss is a prominent inventor based in White Plains, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of cannabinoid receptor modulators. With a total of four patents to her name, her work has the potential to impact the treatment of various diseases and conditions.

Latest Patents

Among her latest patents, one notable invention is focused on the uses of substituted imidazoheterocycles. This invention provides a method for the prophylaxis, treatment, or inhibition of cannabinoid receptor-associated diseases, disorders, or conditions in mammalian subjects. The method involves administering a compound with a specific structure, which is effective in treating pain and inflammatory diseases. Another patent details substituted imidazoheterocyclic compounds that serve as modulators of cannabinoid receptors, offering therapeutic benefits for conditions such as pain, inflammation, and pruritis.

Career Highlights

Carla M. Gauss is currently associated with Cara Therapeutics, Inc., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a strong focus on cannabinoid receptor research, which has garnered attention for its potential therapeutic applications.

Collaborations

Throughout her career, Carla has collaborated with notable colleagues, including Gary Gustafson and R. Paul Beckett. These collaborations have contributed to the advancement of her research and the successful development of her patented inventions.

Conclusion

Carla M. Gauss exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations highlight her commitment to advancing medical science and improving patient care.